Characterization of Antibody and Cytotoxic T Lymphocyte Responses to Human Influenza Virus H3 Haemagglutinin Expressed from the Haemagglutinin Locus of Vaccinia Virus

References

1. Bennink J. R., Yewdell J. W., Smith G. L., Moller C., Moss B. 1984; Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature; London: 311578–579
   [Google Scholar]
2. Coupar B. E. H., Andrew M. E., Both G. W., Boyle D. B. 1986; Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. European Journal of Immunology 16:1479–1487
   [Google Scholar]
3. Davenport F. M., Hennessy A. V., Brandon F. M., Webster R. G., Barrett C. D.JR Lease G. O. 1964; Comparisons of serologic and febrile responses in human to vaccination with influenza A viruses or their hemagglutinins. Journal of Laboratory and Clinical Medicine 63:5–13
   [Google Scholar]
4. Itamura S., Morikawa Y., Shida H., Nerome K., Oya A. 1990; Biological and immunological characterization of influenza virus haemagglutinin expressed from haemagglutinin locus of vaccinia virus. Journal of General Virology 71:1293–1301
   [Google Scholar]
5. Jakeman K. J., Smith H., Sweet C. 1989; Mechanism of immunity to influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins. Journal of General Virology 70:1523–1531
   [Google Scholar]
6. Joklik W. K. 1962; The purification of four strains of poxvirus. Virology 18:9–18
   [Google Scholar]
7. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
   [Google Scholar]
8. Mackett M., Smith G. L., Moss B. 1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
   [Google Scholar]
9. Moss B., Flexner C. 1987; Vaccinia virus expression vectors. Annual Review of Immunology 5:305–324
   [Google Scholar]
10. Ohishi K., Maruyama T., Shida H., Nishimaki J., Miki K., Sagata N., Ikawa Y., Sugimoto M. 1988; Immunogenicity of a recombinant vaccinia virus expressing an envelope glycoprotein of bovine leukaemia virus. Vaccine 7:428–432
    [Google Scholar]
11. Panicali D., Paoletti E. 1982; Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proceedings of the National Academy of Sciences, U.S.A 79:4927–4931
    [Google Scholar]
12. Panicali D., Davis S. W., Weinberg R. L., Paoletti E. 1983; Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin. Proceedings of the National Academy of Sciences, U.S.A 80:5364–5368
    [Google Scholar]
13. Perkus M. E., Piccini A., Lipinskas B. R., Paoletti E. 1985; Recombinant vaccinia virus: immunization against multiple pathogens. Science 229:981–984
    [Google Scholar]
14. Perkus M. E., Panicali D., Mercer S., Paoletti E. 1986; Insertion and deletion mutants of vaccinia virus. Virology 152:285–297
    [Google Scholar]
15. Perkus M. E., Limbach K., Paoletti E. 1989; Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. Journal of Virology 63:3829–3836
    [Google Scholar]
16. Rooney J. F., Wohlenberg C., Cremer K. J., Moss B., Notkins A. L. 1988; Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long term protection and effect of revaccination. Journal of Virology 62:1530–1534
    [Google Scholar]
17. Rota P. A., Shaw M. W., Kendal A. P. 1987; Comparison of the immune response to variant influenza type B hemagglutinins expressed in vaccinia virus. Virology 161:269–275
    [Google Scholar]
18. Rota P. A., Shaw M. W., Kendal A. P. 1989; Cross-protection against microvariants of influenza virus type B by vaccinia viruses expressing haemagglutinins from egg- or MDCK cell-derived subpopulations of influenza virus type B/England/222/82. Journal of General Virology 70:1533–1537
    [Google Scholar]
19. Shida H., Tochikura T., Sato T., Konno T., Hirayoshi K., Seki M., Ito Y., Hatanaka M., Hinuma Y., Sugimoto M., Takahashi-Nishimaki F., Maruyama T., Miki K., Suzuki K., Morita M., Sashiyama H., Hayami M. 1987; Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO Journal 6:3379–3384
    [Google Scholar]
20. Shida H., Hinuma Y., Hatanaka M., Morita M., Kidokoro M., Suzuki K., Maruyama T., Takahashi-Nishimaki F., Sugimoto M., Kitamura R., Miyazawa T., Hayami M. 1988; Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene. Journal of Virology 62:4474–4480
    [Google Scholar]
21. Smith G. L., Murphy B. R., Moss B. 1983; Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proceedings of the National Academy of Sciences, U.S.A 80:7155–7159
    [Google Scholar]
22. Townsend A. R. M., Bastin J., Gould K., Brownlee G. G. 1986; Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence. Nature; London: 324:575–577
    [Google Scholar]
23. Townsend A., Bastin J., Gould K., Brownlee G., Andrew M., Coupar B., Boyle D., Chan S., Smith G. 1988; Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. Journal of Experimental Medicine 168:1211–1224
    [Google Scholar]
24. Tsukiyama K., Yoshikawa Y., Kamata H., Imaoka K., Asano K., Funahashi S., Maruyama T., Shida H., Sugimoto M., Yamanouchi K. 1989; Development of heat-stable recombinant rinderpest vaccine. Archives of Virology 107:225–235
    [Google Scholar]
25. Wood J. M., Oxford J. S., Dunleavy U., Newman R. W., Major D., Robertson J. S. 1989; Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology 171:214–221
    [Google Scholar]
26. Yewdell J. W., Hackett C. J. 1989; Specificity and function of T lymphocytes induced by influenza A viruses. In The Influenza Viruses pp. 361–429 Krug R. M. Edited by New York: Plenum Press;
    [Google Scholar]